BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

946 related articles for article (PubMed ID: 19670379)

  • 21. The effect of beta-interferon therapy on myelin basic protein-elicited CD4+ T cell proliferation and cytokine production in multiple sclerosis.
    Hedegaard CJ; Krakauer M; Bendtzen K; Sørensen PS; Sellebjerg F; Nielsen CH
    Clin Immunol; 2008 Oct; 129(1):80-9. PubMed ID: 18653385
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interferon-beta up-regulates the expression of co-stimulatory molecules CD80, CD86 and CD40 on monocytes: significance for treatment of multiple sclerosis.
    Marckmann S; Wiesemann E; Hilse R; Trebst C; Stangel M; Windhagen A
    Clin Exp Immunol; 2004 Dec; 138(3):499-506. PubMed ID: 15544628
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IL-27 suppresses RANKL expression in CD4+ T cells in part through STAT3.
    Kamiya S; Okumura M; Chiba Y; Fukawa T; Nakamura C; Nimura N; Mizuguchi J; Wada S; Yoshimoto T
    Immunol Lett; 2011 Jul; 138(1):47-53. PubMed ID: 21453726
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [T-cell interferon-gamma, tumor necrosis factor-alpha and interleukin-6 receptor binding in patients with multiple sclerosis. Effects of interferon-beta-1b treatment].
    Bongioanni P; Romano MR; Boccardi B; Lombardo F; Moscato G; Mosti S; Baldini C; Nuti S; Meucci G; Rossi B
    Rev Neurol; 1999 Nov 16-30; 29(10):893-9. PubMed ID: 10637835
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased osteopontin expression in dendritic cells amplifies IL-17 production by CD4+ T cells in experimental autoimmune encephalomyelitis and in multiple sclerosis.
    Murugaiyan G; Mittal A; Weiner HL
    J Immunol; 2008 Dec; 181(11):7480-8. PubMed ID: 19017937
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel immunomodulatory properties of cirsilineol through selective inhibition of IFN-gamma signaling in a murine model of inflammatory bowel disease.
    Sun Y; Wu XX; Yin Y; Gong FY; Shen Y; Cai TT; Zhou XB; Wu XF; Xu Q
    Biochem Pharmacol; 2010 Jan; 79(2):229-38. PubMed ID: 19698701
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Th17-like developmental process leads to CD8(+) Tc17 cells with reduced cytotoxic activity.
    Huber M; Heink S; Grothe H; Guralnik A; Reinhard K; Elflein K; Hünig T; Mittrücker HW; Brüstle A; Kamradt T; Lohoff M
    Eur J Immunol; 2009 Jul; 39(7):1716-25. PubMed ID: 19544308
    [TBL] [Abstract][Full Text] [Related]  

  • 28. pSTAT1, pSTAT3, and T-bet expression in peripheral blood mononuclear cells from relapsing-remitting multiple sclerosis patients correlates with disease activity.
    Frisullo G; Angelucci F; Caggiula M; Nociti V; Iorio R; Patanella AK; Sancricca C; Mirabella M; Tonali PA; Batocchi AP
    J Neurosci Res; 2006 Oct; 84(5):1027-36. PubMed ID: 16865709
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Defective production of anti-inflammatory cytokine, TGF-beta by T cell lines of patients with active multiple sclerosis.
    Mokhtarian F; Shi Y; Shirazian D; Morgante L; Miller A; Grob D
    J Immunol; 1994 Jun; 152(12):6003-10. PubMed ID: 8207225
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transglutaminase 2 exacerbates experimental autoimmune encephalomyelitis through positive regulation of encephalitogenic T cell differentiation and inflammation.
    Oh K; Park HB; Seo MW; Byoun OJ; Lee DS
    Clin Immunol; 2012 Nov; 145(2):122-32. PubMed ID: 23001131
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Peripheral blood CD4+ T lymphocytes from multiple sclerosis patients are characterized by higher PSGL-1 expression and transmigration capacity across a human blood-brain barrier-derived endothelial cell line.
    Bahbouhi B; Berthelot L; Pettré S; Michel L; Wiertlewski S; Weksler B; Romero IA; Miller F; Couraud PO; Brouard S; Laplaud DA; Soulillou JP
    J Leukoc Biol; 2009 Nov; 86(5):1049-63. PubMed ID: 19696154
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Suppressive influences of IFN-alpha on IL-17 expression in human CD4+ T cells.
    Hirohata S; Shibuya H; Tejima S
    Clin Immunol; 2010 Mar; 134(3):340-4. PubMed ID: 20015694
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intrathecal activation of the IL-17/IL-8 axis in opticospinal multiple sclerosis.
    Ishizu T; Osoegawa M; Mei FJ; Kikuchi H; Tanaka M; Takakura Y; Minohara M; Murai H; Mihara F; Taniwaki T; Kira J
    Brain; 2005 May; 128(Pt 5):988-1002. PubMed ID: 15743872
    [TBL] [Abstract][Full Text] [Related]  

  • 34. IL-27 inhibits the development of regulatory T cells via STAT3.
    Huber M; Steinwald V; Guralnik A; Brüstle A; Kleemann P; Rosenplänter C; Decker T; Lohoff M
    Int Immunol; 2008 Feb; 20(2):223-34. PubMed ID: 18156621
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulatory role of DC-derived osteopontin in systemic allergen sensitization.
    Kurokawa M; Konno S; Takahashi A; Plunkett B; Rittling SR; Matsui Y; Kon S; Morimoto J; Uede T; Matsukura S; Kokubu F; Adachi M; Nishimura M; Huang SK
    Eur J Immunol; 2009 Dec; 39(12):3323-30. PubMed ID: 19830723
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease.
    Chabas D; Baranzini SE; Mitchell D; Bernard CC; Rittling SR; Denhardt DT; Sobel RA; Lock C; Karpuj M; Pedotti R; Heller R; Oksenberg JR; Steinman L
    Science; 2001 Nov; 294(5547):1731-5. PubMed ID: 11721059
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapeutic efficacy of IL-17 neutralization in murine experimental autoimmune encephalomyelitis.
    Hofstetter HH; Ibrahim SM; Koczan D; Kruse N; Weishaupt A; Toyka KV; Gold R
    Cell Immunol; 2005 Oct; 237(2):123-30. PubMed ID: 16386239
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human dendritic cells stimulated via TLR7 and/or TLR8 induce the sequential production of Il-10, IFN-gamma, and IL-17A by naive CD4+ T cells.
    Lombardi V; Van Overtvelt L; Horiot S; Moingeon P
    J Immunol; 2009 Mar; 182(6):3372-9. PubMed ID: 19265114
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of immunomodulatory treatment on leukocyte cytokine production in multiple sclerosis patients and healthy donors.
    Reske D; Thomas AV; Petereit HF; Fink GR; Schroeter M
    Neuroimmunomodulation; 2009; 16(6):385-91. PubMed ID: 19609087
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interleukin-10-secreting CD4 cells from aged patients with AIDS decrease in-vitro HIV replication and tumour necrosis factor alpha production.
    Andrade RM; Lima PG; Filho RG; Hygino J; Milczanowski SF; Andrade AF; Lauria C; Brindeiro R; Tanuri A; Bento CA
    AIDS; 2007 Aug; 21(13):1763-70. PubMed ID: 17690575
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 48.